Literature DB >> 6220896

Mechanisms of cardiac contraction. What roles for preload, afterload and inotropic state in heart failure?

J Ross.   

Abstract

There is evidence that sarcomere length is maximal and changes little during chronic cardiac enlargement, and that the failing heart does not operate on a true descending limb of the Frank-Starling curve. However, increases of ventricular end-diastolic volume over time clearly are important at the geometrical level in maintaining stroke volume. When the preload reserve is fully utilized, afterload mismatch can exist in the steady state to produce operation of the heart on an apparent descending limb of cardiac function, and further afterload mismatch can be produced by pressure loading under these conditions. The treatment of acute experimental heart failure with a mixed vasodilator (nitroprusside) can lead to an increased cardiac output by afterload reduction only when the venous return curve does not shift downward; thus, the threefold larger shift of central blood volume to the periphery in heart failure (compared to normal) counter balances the venodilator action of nitroprusside. Whether or not the inotropic ceiling of failing myocardium can be reached by positive inotropic agents is unclear, but major hemodynamic benefits in heart failure with many potent inotropic drugs are associated with the direct vasodilating properties of these agents. Thus, there appears to be little role for the Frank-Starling mechanism at the sarcomere level, whereas afterload mismatch and its correction are of major importance provided the venous return can be increased. A degree of inotropic reserve also is available, even in the severely failing myocardium, but more research is needed on the potential costs and benefits of marked sustained inotropic stimulation.

Entities:  

Mesh:

Year:  1983        PMID: 6220896     DOI: 10.1093/eurheartj/4.suppl_a.19

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  12 in total

Review 1.  Left ventricular size and shape: determinants of mechanical signal transduction pathways.

Authors:  Douglas L Mann
Journal:  Heart Fail Rev       Date:  2005-06       Impact factor: 4.214

2.  Digitalis: where are we now?

Authors:  D A Chamberlain
Journal:  Br Heart J       Date:  1985-09

Review 3.  Heart failure following anterior myocardial infarction: an indication for ventricular restoration, a surgical method to reverse post-infarction remodeling.

Authors:  Alfred W H Stanley; Constantine L Athanasuleas; Gerald D Buckberg
Journal:  Heart Fail Rev       Date:  2004-10       Impact factor: 4.214

4.  Dyspnoea of cardiac origin in 67 year old men: (1). Relation to systolic left ventricular function and wall stress. The study of men born in 1913.

Authors:  K Caidahl; H Eriksson; M Hartford; J Wikstrand; I Wallentin; K Svärdsudd
Journal:  Br Heart J       Date:  1988-03

Review 5.  Myocardial Fatigue: a Mechano-energetic Concept in Heart Failure.

Authors:  Patrick Tran; Helen Maddock; Prithwish Banerjee
Journal:  Curr Cardiol Rep       Date:  2022-03-30       Impact factor: 3.955

Review 6.  Modulation of left ventricular dilation remodeling with epicardial restraint devices in postmyocardial infarction heart failure.

Authors:  Veli K Topkara; Srikanth Kondareddy; Douglas L Mann
Journal:  Curr Heart Fail Rep       Date:  2009-12

7.  Use of serum fibroblast growth factor 23 vs. plasma B-type natriuretic peptide levels in assessing the pathophysiology of patients with heart failure.

Authors:  Miki Imazu; Hiroyuki Takahama; Makoto Amaki; Yasuo Sugano; Takahiro Ohara; Takuya Hasegawa; Hideaki Kanzaki; Toshihisa Anzai; Naoki Mochizuki; Hiroshi Asanuma; Masanori Asakura; Masafumi Kitakaze
Journal:  Hypertens Res       Date:  2016-09-29       Impact factor: 3.872

8.  Left heart function in chronic obstructive lung disease.

Authors:  H Seibold; U Roth; R Lippert; J Kohler; S Wieshammer; E Henze; M Stauch
Journal:  Klin Wochenschr       Date:  1986-05-02

9.  Antioxidant treatment improves neonatal survival and prevents impaired cardiac function at adulthood following neonatal glucocorticoid therapy.

Authors:  Youguo Niu; Emilio A Herrera; Rhys D Evans; Dino A Giussani
Journal:  J Physiol       Date:  2013-08-12       Impact factor: 5.182

Review 10.  Are HFpEF and HFmrEF So Different? The Need to Understand Distinct Phenotypes.

Authors:  Alberto Palazzuoli; Matteo Beltrami
Journal:  Front Cardiovasc Med       Date:  2021-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.